WNS Competitive Intelligence Services & Platforms: Empowering Your Strategy with Market & Competitive Insights |Primary and Secondary Competitive Intelligence | R&D Analytics and Insights| Market Intelligence

In the high-stakes terrain of Pharmaceuticals, Competitive Intelligence (CI) is critical in helping organizations accelerate drug development with timely, on-point and cost-optimized go-to-market strategies. By staying abreast of market developments, potential threats and competition and understanding the pulse of different stakeholders, players can continuously finetune their blueprints while entering a new market or therapy area, or launching a product. However, a lack of efficient data collection and processing technologies and skilled resources are limiting intelligence gathering.

WNS is a partner of choice to 30+ Life Sciences brands, delivering top-notch CI for a winning edge. We extend comprehensive primary and secondary research support with our AI-enabled automation tools, extensive conference coverage and interactions with key opinion leaders. The distilled insights enable businesses with foresight to optimize resources, improve agility and remain ahead of the curve.

WNS PRECIZON is our proprietary, industry-proven, cloud-based CI platform. Offered as a SaaS solution, it is powered by AI/ML capabilities and our deep therapeutic expertise. PRECIZON provides users access to multi-source data sets for a single source of truth for greater accuracy, completeness and recency. The content is delivered through an intuitive web-based interface with mobile compatibility and email newsletters.

The advanced features of PRECIZON include a single interface to monitor different pieces of competitor information. It offers multiple components including drug pipeline landscapes, trial timelines, promotional materials, product approvals, company profiles and medical conference materials.

Know More

Thorough. Real-time. Actionable/ Extensive Range of Services for Market Preparedness

End-to-end monitoring for a comprehensive view of the competition to improve decision-making and power growth and profitability

Secondary CI

CI news monitoring
Competitive landscapes and pipeline intelligence
Clinical landscape analysis

Primary CI

Onsite Conference coverage and daily debrief
Abstract compilation and analysis
Booth analysis
Key intelligence topics/Key intelligence questions
co-alignment
Key intelligence topics/Key intelligence questions co-alignment

R&D Analytics and Insights

Clinical trial analysis
Feasibility and situation analysis
Trial timeline analysis and forecasting
Patent and publication analysis

Market-Intelligence

Promotional intelligence
Company and product profile
Market positioning
Go-to-market strategy

Customer Success Stories

Client requirement:

A global pharma company looking to launch a new therapy wanted visibility on a competitor’s pre-launch activities in the human papillomavirus space.

Outcomes:

Helped the client understand the Advisory Committee on Immunization Practices (ACIP)’s role in developing vaccine recommendations
Identified different consumer activities for raising disease awareness for more than 6 months to build a market understanding
Competitor's presence in various medical congresses before the launch provided a complete overview of how the publication volume has established a long-term evidence, along with the possibility of partnering/ sponsoring of professional medical societies

Client requirement:

A US-based women’s health company sought WNS’ help in conducting competitor analysis in the women’s health space with a monthly CI report.

Outcomes:

Identified the product strategy of key competitors in the women’s health space
Planned an effective promotional campaign for their molecule by analyzing competitor events
Understood the positioning of competitors and formulated a strategic move

Client requirement:

A top global pharma was looking to monitor clinical and regulatory activities for late-stage and registrational trials in platinum-resistant ovarian cancer and provide an overview of early-stage opportunities of novel mechanisms of action in the indication.

Outcomes:

Identified developments in competing trials, thereby providing a detailed overview of the level of threat faced
Scoped out the opportunities available for M&A based on our early-stage mechanism of action landscape for the indication

GET IN TOUCH

What Our Clients Say

Our partnership with WNS over this last decade has been ground-breaking in many different dimensions. Innovation is the DNA of our company and we are proud of what has been achieved by a dedicated team of people in our site in Gurgaon.

SVP, Global Commercial Strategy & Platforms, Top 10 pharma company

In line with the expansion of this highly dynamic competitive landscape, WNS staff have risen to the challenge with their knowledge, attention to detail and flexibility.

Deputy Director CI, Hematology & Ophthalmology, Leading global pharma company

The WNS Advantage

Domain expertise: A global talent pool of medical professionals including more than 100 doctors, nurses and pharmacists, and more than 160+ CI experts
Conference coverage capabilities: Our end-to-end services cover conference planning, daily debrief reports and comprehensive insights and summaries
Innovative futuristic solutions: A dedicated innovation team that focuses on transformation, automation and new product development
Industry recognition: Winner’s Circle in the HfS Blueprint Report for the Pharmaceuticals Industry and Stevie International Award 2021 for PRECIZON– Competitive Intelligence Solution

REQUEST A CONSULTATION

WNS Competitive Intelligence

Get the First-to-Market advantage with Intuitive Market and Competitive Intelligence

18+

More Than 160

15+

17+

1224+

Thorough. Real-time. Actionable/ Extensive Range of Services for Market Preparedness

Secondary CI

Primary CI

R&D Analytics and Insights

Market-Intelligence

Customer Success Stories

Client requirement:

Outcomes:

Client requirement:

Outcomes:

Client requirement:

Outcomes:

What Our Clients Say

Our partnership with WNS over this last decade has been ground-breaking in many different dimensions. Innovation is the DNA of our company and we are proud of what has been achieved by a dedicated team of people in our site in Gurgaon.

SVP, Global Commercial Strategy & Platforms, Top 10 pharma company

In line with the expansion of this highly dynamic competitive landscape, WNS staff have risen to the challenge with their knowledge, attention to detail and flexibility.

Deputy Director CI, Hematology & Ophthalmology, Leading global pharma company

The WNS Advantage